Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PRELP contributors: mct/npt - updated : 24-12-2013
HGNC name proline arginine-rich end leucine-rich repeat protein
HGNC id 9357
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • basic N terminal ARG/PRO-rich binding domain
  • a heparin-binding N terminus has been shown to have antimicrobial activity
  • a GAG-binding domain ((hbd)
  • 10 characteristic leucine-rich repeats flanked by cysteine loops in both the N and C termini
  • a N-linked glycosylation site (NKSIT motifs) in the LRR region
  • a putative secretory signal sequence and several glycosylation sites
  • HOMOLOGY
    interspecies homolog to murine Prelp
    intraspecies homolog to FMOD
    Homologene
    FAMILY
  • small leucine-rich proteoglycan (SLRP) family
  • class II subfamily
  • CATEGORY structural protein
    SUBCELLULAR LOCALIZATION extracellular
        intracellular
    intracellular,cytoplasm,organelle,Golgi
    intracellular,cytoplasm,organelle,lysosome
    text
  • cuticle, basement membrane
  • localize to the physis (Shapiro 2009)
  • normally expressed in extracellular matrix of collagen-rich tissues
  • basic FUNCTION
  • functions as a molecule anchoring basement membranes to the underlying connective tissue
  • maybe anchoring basement membrane to the underlying connective tissue
  • playing a role in skeletal development
  • may play a critical role in regulating the biomechanical properties of scleral extracellular matrix
  • glycosaminoglycan (GAG)- and collagen-binding anchor protein, acting as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis
  • most upregulated gene in the physeal region (Shapiro 2009)
  • inhibits the formation of the membrane attack complex and thereby inhibits all three pathways of complement
  • may act as a local complement inhibitor at basement membranes or at sites with exposed cartilage
  • may down-regulate complement attack at basement membranes and on damaged cartilage and therefore limit pathological complement activation in inflammatory disease such as rheumatoid arthritis
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS ossification
    PATHWAY
    metabolism
    signaling
    a component
  • constituent matrix protein of articular cartilage, 55 kDa
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • binds the basement membrane heparan sulfate proteoglycan perlecan
  • binds triple helical collagens type I and type II
  • interact with the complement inhibitor C4B-binding protein, C4BPB, and C4BPA
  • inhibits the assembly of the alternative C3-convertase
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --over  
    perturbed organization of collagen fibrils in the dermis and the thickness of the hypodermal fat layer was diminished
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS